MedTrace Logo

PatiEnt Neuropsychological outcomeS After laseR Ablation

NCT05075850 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 81

Last updated 2025-04-06

Study results available
· View outcomes & findings →

Summary

PatiEnt Neuropsychological outcomeS After laseR ablation

Conditions

  • Cognitive Change

Interventions

DEVICE

Neuroblate System

All subjects will undergo comprehensive neuropsychological assessment post-LITT per standard of care practice. Visual field testing will be conducted in a subset of enrolled patients.

Sponsors & Collaborators

  • Monteris Medical

    lead INDUSTRY

Principal Investigators

  • Patrick Landazuri, MD · University of Kansas

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-29
Primary Completion
2023-09-30
Completion
2023-09-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05075850 on ClinicalTrials.gov